** Evotec's EVTG.DE shares drop around 16% in volume spike after biotech company Halozyme HALO.O said it withdrew its offer to acquire the German drug development company
** If losses hold Evotec's shares will see their worst day since July; about 1.5 million shares changed hands so far today, around 63% of their 30-day moving average full-day volume
** The stock falls to the bottom of Germany's small-cap index .SDAXI
(Reporting by Tristan Veyet)
((Tristan.chabba@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.